<DOC>
	<DOCNO>NCT03058978</DOCNO>
	<brief_summary>The study evaluate ovary may function use Implanon®/Nexplanon® three year beyond FDA approve duration . Ovarian function assess weekly serum progesterone level . Participants undergo weekly venipuncture total four draw . Participants follow 30 day .</brief_summary>
	<brief_title>Assessing Ovarian Function During Prolonged Implant Use</brief_title>
	<detailed_description>This prospective cohort evaluate ovarian function 210 ENG user three year beyond FDA approve duration . Participants enrol current study , EPIC ( Evaluating Prolonged Use IUD Implant Contraception , NCT02267616 ) , contact via telephone , screen schedule enroll person . After signed consent obtain participant ask complete brief questionnaire demographic information bleeding pattern . Participants undergo blood draw ass serum etonogestrel serum progesterone level . Follow visit include weekly blood draw three week assess serum progesterone level . Participants also complete bleed diary assess daily bleeding pattern 30 day study period . The investigator enroll participant seven time point ; method expiration ( 3 year use ) , six-month interval six year use .</detailed_description>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Enrolled prospective EPIC Prolonged Use Study 1845 year age At expiration beyond end FDAapproved duration use etonogestrelreleasing subdermal implant ( ENG implant =3 year ) Ability consent English Willing able complete require followup study . Have history female sterilization procedure Desire conception next 12 month Had ENG implant remove</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>